Eslead Balance Sheet Health
Financial Health criteria checks 3/6
Eslead has a total shareholder equity of ¥71.9B and total debt of ¥105.9B, which brings its debt-to-equity ratio to 147.3%. Its total assets and total liabilities are ¥187.7B and ¥115.8B respectively. Eslead's EBIT is ¥15.8B making its interest coverage ratio 21.3. It has cash and short-term investments of ¥12.6B.
Key information
147.3%
Debt to equity ratio
JP¥105.93b
Debt
| Interest coverage ratio | 21.3x |
| Cash | JP¥12.61b |
| Equity | JP¥71.91b |
| Total liabilities | JP¥115.83b |
| Total assets | JP¥187.74b |
Recent financial health updates
No updates
Recent updates
Eslead's (TSE:8877) Dividend Will Be Increased To ¥95.00
Dec 31
Eslead (TSE:8877) Has Announced That It Will Be Increasing Its Dividend To ¥95.00
Dec 17Eslead's (TSE:8877) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 03Eslead's (TSE:8877) Profits May Not Reveal Underlying Issues
Nov 21Eslead (TSE:8877) Has Announced A Dividend Of ¥85.00
Sep 26The Market Lifts Eslead Corporation (TSE:8877) Shares 30% But It Can Do More
Sep 04Eslead (TSE:8877) Is Due To Pay A Dividend Of ¥85.00
Jul 26Eslead's (TSE:8877) Dividend Will Be ¥85.00
Jul 12Eslead's (TSE:8877) Shareholders May Want To Dig Deeper Than Statutory Profit
May 23Eslead Corporation (TSE:8877) Stock Rockets 26% But Many Are Still Ignoring The Company
May 22Financial Position Analysis
Short Term Liabilities: 8877's short term assets (¥174.6B) exceed its short term liabilities (¥37.3B).
Long Term Liabilities: 8877's short term assets (¥174.6B) exceed its long term liabilities (¥78.6B).
Debt to Equity History and Analysis
Debt Level: 8877's net debt to equity ratio (129.8%) is considered high.
Reducing Debt: 8877's debt to equity ratio has increased from 43.3% to 147.3% over the past 5 years.
Debt Coverage: 8877's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 8877's interest payments on its debt are well covered by EBIT (21.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 22:11 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Eslead Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.